Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Investigating PSMA differential expression in canine uroepithelial carcinomas to aid disease-based stratification and guide therapeutic selection

Fig. 2

Immunohistochemical detection of PSMA among canine uroepithelial carcinoma cell lines and representative patient samples. (A) PSMA IHC of known human reference control cell lines (LNCaP+, PC3-). (B) PSMA IHC among canine uroepithelial cell lines with grey labeled (top row) representing PCA cell lines and red labelled (bottom row) representing iUC cell lines. (C) PSMA IHC of archived iUC patient sample (red labelled, left) and carcinomas of the prostate (grey labelled, right)

Back to article page